Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma

被引:9
作者
Hernberg, Micaela M. [1 ]
Kivioja, Aarne H. [2 ]
Bohling, Tom O. [3 ]
Janes, Rita J. [1 ]
Wiklund, Tom A. [1 ]
机构
[1] Helsinki Univ Cent Hosp, Dept Oncol, Hus Helsinki 00029, Finland
[2] Helsinki Univ Cent Hosp, Dept Orthopaed & Traumatol, Hus Helsinki 00029, Finland
[3] Univ Helsinki, Dept Pathol, HUSLAB, Helsinki, Finland
关键词
Hyperfractionated; Inoperable; Local control; Outcome; SARCOMA-GROUP EXPERIENCE; NEOADJUVANT CHEMOTHERAPY; EWINGS-SARCOMA; LOCAL-CONTROL; RADIOTHERAPY; EXTREMITIES; FRACTIONATION; PROTOCOL; TUMORS;
D O I
10.1007/s12032-010-9592-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radical surgery is not feasible for all osteosarcoma patients. Overall survival for non-extremity osteosarcoma, as well as for patients with metastatic disease at diagnosis remains poor. For such patients, radical radiotherapy combined with chemotherapy may present an effective treatment approach. This report describes the results of conservative treatment for osteosarcoma patients not suitable for surgery. Seven out of 71 consecutive osteosarcoma patients were treated non-surgically at the Helsinki University Central Hospital either due to the inoperability of the tumour or the patient's choice of therapy. Staging procedures and measurement of tumour size were performed using computed tomography and magnetic resonance imaging. Six patients were treated with chemo-radiotherapy, and one patient received radiotherapy alone. Five patients received computer-assisted dose-planned radiotherapy with curative intent (total dose 60-70.5 Gray), and two patients received radiotherapy as palliation. Radiotherapy relieved symptoms efficiently. Median time to local failure was 2.6 years (range 0.5-16.9+ years). Five year after treatment termination four patients were alive, and one of them remained disease-free. For selected patients not suitable for surgery, radiotherapy combined with chemotherapy provides an option to reduce symptoms caused by the primary tumour and improve quality of life. For some patients, this approach may (even) produce long-term remission.
引用
收藏
页码:1475 / 1480
页数:6
相关论文
共 16 条
[1]   Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide [J].
Bacci, G ;
Briccoli, A ;
Rocca, M ;
Ferrari, S ;
Donati, D ;
Longhi, A ;
Bertoni, F ;
Bacchini, P ;
Giacomini, S ;
Forni, C ;
Manfrini, M ;
Galletti, S .
ANNALS OF ONCOLOGY, 2003, 14 (07) :1126-1134
[2]   Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol [J].
Bacci, G ;
Briccoli, A ;
Ferrari, S ;
Longhi, A ;
Mercuri, M ;
Capanna, R ;
Donati, D ;
Lari, S ;
Forni, C ;
DePaolis, M .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (16) :2030-2039
[3]   Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremities [J].
Bolek, TW ;
Marcus, RB ;
Mendenhall, NP ;
Scarborough, MT ;
GrahamPole, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (04) :687-692
[4]   Radiotherapy for local control of osteosarcoma [J].
DeLaney, TF ;
Park, L ;
Goldberg, SI ;
Hug, EB ;
Liebsch, NJ ;
Munzenrider, JE ;
Suit, HD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02) :492-498
[5]   Five-year results in Ewing's sarcoma.: The Scandinavian Sarcoma Group experience with the SSG IX protocol [J].
Elomaa, I ;
Blomqvist, CP ;
Saeter, G ;
Åkerman, M ;
Stenwig, E ;
Wiebe, T ;
Björk, O ;
Alvegård, TA .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (07) :875-880
[6]   Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma [J].
Hundsdoerfer, Patrick ;
Albrecht, Marion ;
Ruehl, Ursula ;
Fengler, Ruediger ;
Kulozik, Andreas E. ;
Henze, Guenter .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (14) :2447-2451
[7]   Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? [J].
Jaffe, N ;
Carrasco, H ;
Raymond, K ;
Ayala, A ;
Eftekhari, F .
CANCER, 2002, 95 (10) :2202-2210
[8]   Primary metastatic osteosarcoma:: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols [J].
Kager, L ;
Zoubek, A ;
Pötschger, U ;
Kastner, U ;
Flege, S ;
Kempf-Bielack, B ;
Branscheid, D ;
Kotz, R ;
Salzer-Kuntschik, M ;
Winkelmann, W ;
Jundt, G ;
Kabisch, H ;
Reichardt, P ;
Jürgens, H ;
Gadner, H ;
Bielack, SS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) :2011-2018
[9]   Postoperative radiotherapy in the management of adult soft tissue sarcoma of the extremities:: Results with two different total dose, fractionation, and overall treatment time schedules [J].
Le Péchoux, C ;
Le Deley, MC ;
Delaloge, S ;
Lartigau, E ;
Levy-Piedbois, C ;
Bonvalot, S ;
Le Cesne, A ;
Missenard, G ;
Terrier, P ;
Vanel, D ;
Genin, J ;
Fontaine, F .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (04) :879-886
[10]   Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities [J].
Machak, GN ;
Tkachev, SI ;
Solovyev, YN ;
Sinyukov, PA ;
Ivanov, SM ;
Kochergina, NV ;
Ryjkov, AD ;
Tepliakov, VV ;
Bokhian, BY ;
Glebovskaya, VV .
MAYO CLINIC PROCEEDINGS, 2003, 78 (02) :147-155